Latest Financials News

Greenvale Energy has sharpened its uranium exploration focus with new step-out targets at Oasis and secured a critical exploration licence at Douglas River, while pushing its Alpha Project into product development.

Geopacific Resources has advanced its Woodlark Gold Project with the Definitive Feasibility Study close to finalisation, underpinned by a $40 million equity raise and promising exploration drilling results. The company is positioning for a development decision in 2026 amid key permit approvals and strategic partnerships.

Hamelin Gold is gearing up for a busy 2026 with planned drilling across three key Western Australian gold provinces, underpinned by a solid cash position and strategic asset sales.

Cooper Metals has completed all regulatory approvals for a ~1,400m RC drill program at Ardmore North, targeting Q2 2026 commencement. The company also executed a strategic asset swap to acquire the Pyramid Gold Project, backed by a nearly $1 million placement.

Regal Partners Global Investments (ASX:RG1) delivered a resilient March quarter performance, driven by semiconductor stocks and gold, while its short book and currency hedging added strategic value amid market turbulence.

Fat Prophets Global Contrarian Fund (ASX: FPC) is raising up to $8.45 million through a pro-rata rights issue priced at a premium, offering one option per new share. The issue is partly underwritten and sees directors committing to full participation.

Neuren Pharmaceuticals reported a solid A$30.4 million net profit in 2025, powered by a 15% rise in DAYBUE® royalties. The company is progressing its NNZ-2591 Phase 3 trial for Phelan-McDermid syndrome and has initiated a share buy-back amid perceived undervaluation.

Stakk Ltd (ASX: SKK) has delivered a striking 272% jump in gross receipts to $5.36 million in Q3 FY26, reversing prior cash outflows with a positive net cash flow of $2.25 million and closing the quarter with $17.34 million in cash.

Nexion Group plans to delist from the ASX in April 2026 after disposing of its main assets, appointing Robert Minson as CEO to spearhead software acquisitions aimed at rebuilding the company for re-admission.

Invex Therapeutics reported promising preclinical findings on Exenatide’s effects in a human Alzheimer's disease model, alongside a steady cash position and reduced operating outflows in Q3 FY26.

Duketon Mining has kicked off its maiden drilling program at the Barlee Gold Project, targeting multiple large gold anomalies, while reporting a combined nickel resource exceeding 100,000 tonnes across its Rosie and C2 deposits.

Ionic Rare Earths (ASX: IXR) has secured a £12 million UK government grant offer for its Belfast rare earth magnet recycling facility and is progressing its Brazilian JV and Ugandan heavy rare earths project, reinforcing its role in ex-China supply chains.